chr5-149858559-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000440.3(PDE6A):c.*2336C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.435 in 152,036 control chromosomes in the GnomAD database, including 14,544 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.43 ( 14544 hom., cov: 32)
Exomes 𝑓: 0.41 ( 3 hom. )
Failed GnomAD Quality Control
Consequence
PDE6A
NM_000440.3 3_prime_UTR
NM_000440.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.365
Genes affected
PDE6A (HGNC:8785): (phosphodiesterase 6A) This gene encodes the cyclic-GMP (cGMP)-specific phosphodiesterase 6A alpha subunit, expressed in cells of the retinal rod outer segment. The phosphodiesterase 6 holoenzyme is a heterotrimer composed of an alpha, beta, and two gamma subunits. cGMP is an important regulator of rod cell membrane current, and its dynamic concentration is established by phosphodiesterase 6A cGMP hydrolysis and guanylate cyclase cGMP synthesis. The protein is a subunit of a key phototransduction enzyme and participates in processes of transmission and amplification of the visual signal. Mutations in this gene have been identified as one cause of autosomal recessive retinitis pigmentosa. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-149858559-G-A is Benign according to our data. Variant chr5-149858559-G-A is described in ClinVar as [Benign]. Clinvar id is 351945.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDE6A | NM_000440.3 | c.*2336C>T | 3_prime_UTR_variant | 22/22 | ENST00000255266.10 | NP_000431.2 | ||
PDE6A | NM_001410788.1 | c.*2336C>T | 3_prime_UTR_variant | 20/20 | NP_001397717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDE6A | ENST00000255266.10 | c.*2336C>T | 3_prime_UTR_variant | 22/22 | 1 | NM_000440.3 | ENSP00000255266 | P1 | ||
PDE6A | ENST00000508173.5 | n.5103C>T | non_coding_transcript_exon_variant | 20/20 | 1 | |||||
PDE6A | ENST00000613228.1 | c.*2336C>T | 3_prime_UTR_variant | 20/20 | 5 | ENSP00000478060 |
Frequencies
GnomAD3 genomes AF: 0.435 AC: 66023AN: 151918Hom.: 14531 Cov.: 32
GnomAD3 genomes
AF:
AC:
66023
AN:
151918
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.413 AC: 19AN: 46Hom.: 3 Cov.: 0 AF XY: 0.425 AC XY: 17AN XY: 40
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
19
AN:
46
Hom.:
Cov.:
0
AF XY:
AC XY:
17
AN XY:
40
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.435 AC: 66084AN: 152036Hom.: 14544 Cov.: 32 AF XY: 0.434 AC XY: 32237AN XY: 74296
GnomAD4 genome
AF:
AC:
66084
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
32237
AN XY:
74296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1308
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Retinitis pigmentosa Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at